A new London survey suggests drug-related grief and harm are touching LGBTQ+ communities at striking levels. The report, based on 1,156 recent recreational drug users, highlights particular risks linked to GHB/GBL, crystal meth and mephedrone, while warning that support must reflect how people actually describe their experiences.

Essential Takeaways

  • Drug-related bereavement: 28% of respondents said they'd lost someone to a drug-related death in the previous five years.
  • Higher local figure: That rose to 33% among respondents in Lambeth, Southwark and Lewisham.
  • Chemsex drug harms: Users of GHB/GBL, crystal meth or mephedrone were nearly three times more likely to describe their drug use as harmful.
  • Overdose risk: Around two-thirds of GHB/GBL users reported passing out or falling asleep unexpectedly.
  • Important limitation: The self-selected sample was largely made up of gay, cisgender men, so it isn't a representative picture of every LGBTQ+ person in London.

A sobering picture of grief across queer communities

The sharpest finding is also the hardest to ignore: more than one in four people surveyed had experienced a drug-related bereavement in the past five years. In some south London boroughs, the proportion climbed to one in three, giving the figures a deeply personal edge. Attitude reported similar concern around the survey's findings, which place drug-related loss within a wider LGBTQ+ health conversation.

The results don't suggest that every LGBTQ+ person faces the same risk, nor that drug use automatically leads to tragedy. They do, however, show how bereavement can ripple through friendship groups, partners and chosen families. As London's drug death figures continue to attract official scrutiny, community organisations say prevention and support need to sit alongside emergency responses.

GHB/GBL and crystal meth stand out

The survey points to particularly serious harm among people using GHB/GBL, crystal meth and mephedrone. Respondents who had used at least one of these substances were almost three times as likely to describe their recreational drug use as harmful as those who used other drugs.

GHB/GBL appears especially associated with sudden loss of consciousness. About two-thirds of users said they'd passed out or fallen asleep involuntarily, which the report treats as overdoses. Crystal meth users, meanwhile, reported substantial concern about their consumption, with many using alone at home, where help may be slower to arrive. Research indexed by PubMed has also added to the evidence base around drug-related risks affecting LGBTQ+ populations.

Why the word "chemsex" doesn't fit everyone

One of the report's more useful cautions is linguistic. Nearly a third of people using the three highlighted substances said they wouldn't describe their drug use as chemsex, even though that label is often used by services, researchers and media outlets.

That matters because language can decide whether someone feels recognised or pushed into a box. Marc Svensson, founder and director of You Are Loved CIC, said the substances aren't interchangeable and that support providers must listen when people say the term doesn't describe them. London Friend's 2026 chemsex report similarly underlines the value of nuanced, non-judgemental support rather than a one-size-fits-all approach.

What safer support could look like

The practical message is straightforward: services need to meet people where they are. That means clear information about the very different risks of GHB/GBL, crystal meth and mephedrone, alongside advice on avoiding solitary use, recognising overdose signs and seeking urgent help when someone becomes unresponsive.

It also means making space for grief. Someone may be seeking help because of their own drug use, a partner's use, or the death of a friend, and those needs won't always look alike. London Friend and other specialist organisations can offer a starting point, while anyone facing an immediate medical emergency should contact emergency services.

A valuable warning, but not a complete snapshot

The survey is based on people who chose to take part and who had used at least one recreational drug in the previous year. Most respondents were gay men, cisgender men and white people, so the results shouldn't be presented as a population-wide estimate for all LGBTQ+ Londoners.

That limitation doesn't make the findings unimportant. It simply shows where further research is needed, particularly among lesbians, bisexual people, trans people, non-binary people and LGBTQ+ people from racialised communities. Public bodies, including the Greater London Authority, have continued to examine ways to reduce drug deaths, but effective policy will depend on listening to the communities most affected.

Small details matter here: the right words, the right specialist service and a response that treats grief as seriously as physical risk. Explore support early, before a crisis makes the choices for you.

Source Reference Map

Story idea inspired by: [1]

Sources by paragraph: